Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

JAK inhibitors show promise for treating alopecia areata but their effectiveness and safety are still debated.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Gray hair can potentially be reversed, leading to new treatments.

Chemistry42 effectively creates and optimizes new molecules for drug discovery.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Laser therapy might help regrow hair in alopecia totalis better than steroids alone.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

An 11-year-old girl with severe hair loss regrew and repigmented her hair after JAK inhibitor treatment.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

Kaempferol helps skin stem cells grow and may improve skin thickness due to its 3-OH group.

Removing STAT5 from 3D-cultured human skin cells reduces their ability to grow hair.

The model can effectively test gene functions and drug responses in human skin.

Ginsenoside Rd may help improve skin aging by increasing collagen in the skin.

Aging reduces skin cell renewal and defense against germs due to TGFbeta, but blocking TGFbeta could help restore these functions.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.